These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 26342485)
21. Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials. Cardoso R; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Brouwer MA; Calkins H Clin Cardiol; 2019 Jan; 42(1):198-205. PubMed ID: 30460702 [TBL] [Abstract][Full Text] [Related]
22. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy. Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484 [TBL] [Abstract][Full Text] [Related]
23. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103 [TBL] [Abstract][Full Text] [Related]
24. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Romero J; Cerrud-Rodriguez RC; Diaz JC; Michaud GF; Taveras J; Alviz I; Grupposo V; Cerna L; Avendano R; Kumar S; Kirchhof P; Natale A; Di Biase L Europace; 2018 Oct; 20(10):1612-1620. PubMed ID: 29982383 [TBL] [Abstract][Full Text] [Related]
25. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation. Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077 [TBL] [Abstract][Full Text] [Related]
26. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis. Deitelzweig S; Farmer C; Luo X; Li X; Vo L; Mardekian J; Fahrbach K; Ashaye A Curr Med Res Opin; 2018 Mar; 34(3):487-498. PubMed ID: 29188721 [TBL] [Abstract][Full Text] [Related]
27. Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation. Baker WL; Phung OJ Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):711-9. PubMed ID: 22912382 [TBL] [Abstract][Full Text] [Related]
29. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation. Romero J; Cerrud-Rodriguez RC; Alviz I; Diaz JC; Rodriguez D; Arshad S; Cerna L; Taveras J; Grupposo V; Natale A; Garcia M; Di Biase L JACC Clin Electrophysiol; 2019 Dec; 5(12):1396-1405. PubMed ID: 31857038 [TBL] [Abstract][Full Text] [Related]
30. Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis. Yang J; Zhang X; Wang XY; Zhang C; Chen SZ; Hu SJ BMC Cardiovasc Disord; 2019 Nov; 19(1):261. PubMed ID: 31771529 [TBL] [Abstract][Full Text] [Related]
31. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban. Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA Europace; 2014 Oct; 16(10):1443-9. PubMed ID: 25115168 [TBL] [Abstract][Full Text] [Related]
32. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis. Xu WW; Hu SJ; Wu T J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243 [No Abstract] [Full Text] [Related]
34. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation. Okishige K; Nakamura T; Aoyagi H; Kawaguchi N; Yamashita M; Kurabayashi M; Suzuki H; Asano M; Shimura T; Yamauchi Y; Sasano T; Hirao K J Cardiol; 2017 Jan; 69(1):11-15. PubMed ID: 27160710 [TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. Hohnloser SH; Camm AJ Europace; 2013 Oct; 15(10):1407-11. PubMed ID: 23954917 [TBL] [Abstract][Full Text] [Related]
36. Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis. Caldeira D; Costa J; Ferreira JJ; Lip GY; Pinto FJ Clin Res Cardiol; 2015 Jul; 104(7):582-90. PubMed ID: 25643952 [TBL] [Abstract][Full Text] [Related]
37. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048 [TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Morimoto T; Crawford B; Wada K; Ueda S J Cardiol; 2015 Dec; 66(6):466-74. PubMed ID: 26162944 [TBL] [Abstract][Full Text] [Related]
39. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin. Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285 [TBL] [Abstract][Full Text] [Related]
40. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]